Extended titration Some researchers prefer a very gradual titration: increasing by 1.25 mg every 4 weeks instead of the standard 2.5 mg
RUO labeling does not support personal-use, clinical-use, veterinary-use, therapeutic-use, wellness-use, cosmetic-use, or product-use positioning
Return to Article Details Diabetes medications with cardiovascular protection as we enter a new decade: can SGLT2 inhibitors, long-acting GLP-1 receptor agonists, pioglitazone and metformin complement each other to save lives?
Cut all meal portions in half immediately
Conclusions GLP-1 analogues are an effective treatment for weight loss, and the addition of bupropion/naltrexone is associated with greater weight loss including in patients who are initially non-responsive to GLP-1 analogues